Translating research into practice: Are physicians following evidence-based guidelines in the treatment of hypertension?

Medical Care Research and Review

Volumn 61, Issue 4, 2004, Pages 453-473

  Holmes, Julia S ^a   Shevrin, Matt ^b   Goldman, Beth ^b   Share, David ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b Blue Cross Blue Shield of Michigan Cardiovascular Consortium   (United States)

Author keywords

Adherence to treatment guidelines; Antihypertensive drug therapy; Evidence based medicine; Health care quality; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RESEARCH; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DIURETICS; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; MICHIGAN; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES;

EID: 8544242725     PISSN: 10775587     EISSN: None     Source Type: Journal    
DOI: 10.1177/1077558704269501     Document Type: Article

References (41)

1. Appel, L. J. 2002. The verdict from ALLHAT - thiazide diuretics are the preferred initial therapy for hypertension. Journal of the American Medical Association 288:3039-42.
2. Asch, S. M., E. A. Kerr, P. Lapuerta, A. Law, and E. A. McGlynn. 2001. A new approach for measuring quality of care for women with hypertension. Archives of Internal Medicine 161:1329-35.
3. August P., and S. Oparil. 1999. Hypertension in women. Journal of Clinical Endocrinology & Metabolism 84:1862-66.
4. Avorn, J., M. Chen, and R. Hartley. 1982. Scientific versus commercial sources of influence on the prescribing behavior of physicians. American Journal of Medicine 73:4-8.
5. Burt, V. L., P. Whelton, E. J. Rocella, C. Brown, J. A. Cutler, M. Higgins, M. J. Horan, and D. Labarthe. 1995. Prevalence of hypertension in the U.S. adult population: Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25:305-13.
6. Burton, W. D., and D. J. Conti. 1998. Use of an integrated health data warehouse to measure the employer costs of five chronic disease states. Disease Management 1:17-26.
7. Cabana, M. D., C. S. Rand, N. R. Powe, A. W. Wu, M. H. Wilson, P. C. Abboud, and H. R. Rubin. 1999. Why don't physicians follow clinical practice guidelines? Journal of the American Medical Association 282:1458-65.
8. Chobanian, A. V., G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright Jr., and E. J. Roccella. 2003. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Journal of the American Medical Association 289:2560-72.
9. Douglas, J. G., G. L. Bakris, M. Epstein, K. C. Ferdinand, C. Ferrario, J. M. Flack, K. A. Jamerson, W. E. Jones, J. Haywood, R. Maxey, E. O. Ofili, E. Saunders, E. L. Schriffrin, D. A. Sica, J. R. Sowers, and D. G. Vidt. 2003. Management of high blood pressure in African Americans: Consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Archives of Internal Medicine. 163:525-41.
10. Druss, B. G., S. C. Marcus, M. Olfson, T. Tanielian, L. Elinson, and H. A. Pincus. 2002. Comparing the national economic burden of five chronic conditions. Health Affairs 20:233-41.
11. Hodgson T. A., and A. J. Cohen. 1999. Medical care expenditures for selected circulatory diseases - opportunities for reducing national health expenditures. Medical Care 37:994-1012.
12. Hodgson, T. A., and L. Cai. 2001. Medical care expenditures for hypertension, its complications, and its comorbidities. Medical Care 39:599-615.
13. Hyman D. J., and V. N. Pavlik. 2000. Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Archives of Internal Medicine 160 (15): 2281-86.
14. Institute for Health and Productivity Management. 2000. Industry specific medical care utilization and expenditures. Irving, TX: Kaiser Family Foundation.
15. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. 1997. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood pressure (JNC VI). Archives of Internal Medicine 157:2413-46.
16. Kaiser Family Foundation. 2001. Prescription drug trends: A chartbook update. Menlo Park, CA: Kaiser Family Foundation.
17. Kizer, J. R., and S. E. Kimmel. 2001. Epidemiologic review of the calcium channel blocker drugs. Archives of Internal Medicine 161:1145-58.
18. Knight, E. L., R. L. Glynn, and R. Levin. 2000. Failure of evidence-based medicine in the treatment of hypertension in older patients. Journal of General Internal Medicine 15:702-09.
19. Lipsky, M. S., and C. A. Taylor. 1997. The opinions and experiences of family physicians regarding direct-to-consumer advertising. Journal of Family Practice 45:495-99.
20. Maniolo, T. A., J. A. Cutler, C. D. Furberg, B. M. Psaty, P. K. Whelton, and W. B. Applegate. 1995. Trends in pharmacologic management of hypertension in the United States. Archives of Internal Medicine 155:829-37.
21. MedAdNews. 2001. Antihypertensive market to be worth more than $52 billion by 2007. March 27.
22. Moser, M. 1998. Why are physicians not prescribing diuretics more frequently in the management of hypertension? Journal of the American Medical Association 1813-16.
23. Moser, M. 1999. National recommendations for the pharmacological treatment of hypertension: Should they be revised? Archives of Internal Medicine 159:1403-06.
24. Moser, M. 2001. Is it time for a new approach to the initial treatment of hypertension? Archives of Internal Medicine 161:1140-44.
25. Mottur-Pilson, C., V. Snow, and K. Bartlett. 2001. Physician explanations for failing to comply with "best practices. Effective Clinical Practice 4:207-13.
26. Nelson, C. R., and D. A. Knapp. 2000. Trends in antihypertensive drug therapy of ambulatory patients by U.S. office-based physicians. Hypertension 36:600-03.
27. Oliveria, S. A., P. Lapuerta, B. D. McCarthy, G. J. L'Italien, D. R. Berlowitz, and S. M. Asch. 2002. Physician-related barriers to the effective management of uncontrolled hypertension. Archives of Internal Medicine 162:413-20.
28. Pahor, M., B. M. Psaty, M. H. Alderman, W. B. Applegate, J. D. Williamson, C. Cavazzini, and C. D. Furberg. 2000. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomized controlled trials. The Lancet 356 (9246): 1949.
29. Psaty, B. M., C. Rhoads, and C. D. Furberg. 2000. Evidence-based medicine: Worship of form and treatment of high blood pressure. Journal of General Internal Medicine 15:755-56.
30. Psaty, B. M., N. L. Smith, D. S. Siscovick, T. D. Koepsell, N. S. Weiss, S. R. Heckbert, R. N. Lemaitre, E. H. Wagner, and C. D. Furberg. 1997. Health outcomes associated with anti-hypertensive therapies used as first-line agents: a systematic review and meta-analysis. Journal of the American Medical Association 277:739-45.
31. Psaty, B. M., S. R. Heckbert, T. D. Koepsell, D. S. Siscovick, T. E. Raghunathan, N. S. Weiss, F. R. Rosendaal, R. N. Lemaitre, N. L. Smith, P. W. Wahl, E. H. Wagner, and C. D. Furberg. 1995. The risk of myocardial infarction associated with antihypertensive drug therapies. Journal of the American Medical Association 274:620-25.
32. Psaty, B. M., T. Lumley, C. D. Furberg, G. Schellenbaum, M. Pahor, M. A. Alderman, and N. S. Weiss. 2003. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. Journal of the American Medical Association 289:2534-44.
33. Public Health Service and Health Care Financing Administration. 1998. International Classification of Diseases (9th rev.), Clinical Modification (6th ed.). Washington, DC: Public Health Service.
34. Quam, L., L. B. M. Ellis, P. Venus, J. Clouse, C. Taylor, and S. Leatherman. 1993. Using claims data for epidemiologic research: The concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population. Medical Care 31 (6): 498-507.
35. Reed, M. C., K. Devers, and B. Landon. 2003. Physicians and care management: More acceptance than you think. Issue brief no. 60. Washington DC: Center for Studying Health System Change.
36. Rosenthal, M. B., E. R. Berndt, J. M. Donohue, R. G. Frank, and A. M. Epstein. 2002. Promotion of prescription drugs to consumers. New England Journal of Medicine 346:498-505.
37. Siegel, D. 2000. The influence of national guidelines on antihypertensive prescribing patterns. Current Hypertension Reports 3:247-52.
38. Siegel, D., and J. Lopez. 1997. Trends in antihypertensive drug use in the United States: Do the JNC V recommendations affect prescribing? Journal of the American Medical Association 278 (21): 1745-48.
39. Siegel, D., J. Lopez, and J. Meier. 1998. Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996. American Journal of Hypertension 11 (11): 1271-78.
40. Vasan, R. S., A. Beiser, S. Seshadri, M. G. Larson, W. B. Kannel, R. B. D'Agostini, and D. Levy. 2002. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. Journal of the American Medical Association 287:1003-10.
41. Wassertheil-Smoller, S., G. Anderson, B. M. Psaty, H. R. Black, J. Manson, N. Wong, J. Francis, R. Grimm, T. Kotchen, R. Langer, and N. Lasser. 2000. Hypertension and its treatment in postmenopausal women: Baseline data from the Women's Health Initiative. Hypertension 36:780-89.